Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Colonic Neoplasms 2Rectal Neoplasms 1Prostate Cancer Metastatic Castration Resistant 1Mucositis 1Communicable Diseases 1Colorectal Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1Aberrant Crypt Foci 1

Interventions

Irinotecan 58Bevacizumab 56Oxaliplatin 49Leucovorin 49Fluorouracil 49Capecitabine 45Cetuximab 44pembrolizumab 23IFL protocol 15Nivolumab 11regorafenib 10Panitumumab 10Celecoxib 8Radiotherapy 7Cyclophosphamide 7atezolizumab 6Surgical Procedures, Operative 6Gemcitabine 6Folfox protocol 6Colonoscopy 6trifluridine tipiracil drug combination 5Neoadjuvant Therapy 5Metformin 5Immunohistochemistry 5Biopsy 5tislelizumab 4spartalizumab 4durvalumab 4Trastuzumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Colorectal Neoplasms × Curcumin × Clear all
NCT00003365 2011-01-27

Sulindac and Plant Compounds in Preventing Colon Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡